Voya Investment Management LLC Akero Therapeutics, Inc. Transaction History
Voya Investment Management LLC
- $85.7 Billion
- Q2 2024
A detailed history of Voya Investment Management LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 22,604 shares of AKRO stock, worth $663,201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,604
Previous 19,693
14.78%
Holding current value
$663,201
Previous $497,000
6.64%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AKRO
# of Institutions
168Shares Held
72.7MCall Options Held
178KPut Options Held
164K-
Janus Henderson Group PLC London, X06.88MShares$202 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$164 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$159 Million2.13% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$154 Million3.88% of portfolio
-
Wellington Management Group LLP Boston, MA5.11MShares$150 Million0.02% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.36B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...